FOXD3 and cervical carcinoma: For example, high expression of FOXD3-AS1 has been proved to associate with poor International Federation of Gynecology and Obstetrics stage of cervical cancer, indicating that FOXD3-AS1 could be employed as an independent prognostic biomarker for the prediction of overall survival rates in cervical cancer (32).